Patent · US Expired

Stabilized Pharmaceutical

US5541231A · kind A · utility

81Cited by
19References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 25, 1994
Grant dateJul 30, 1996
Priority date—
Expiry dateAug 25, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This application discloses a method of inhibiting degradation of the antidepressant bupropion hydrochloride in a solid pharmaceutical formulation, so that the pharmaceutical formulation will maintain at least 80% of its initial bupropion potency after one year.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.